Scientific Objectives

The International Conference on Cancer Research & Immuno-Oncology aims to advance scientific understanding of cancer pathogenesis and the evolving role of the immune system in tumor prevention, progression, and treatment. The conference seeks to provide a high-level academic platform where researchers and clinicians can present novel findings in molecular oncology, tumor immunology, genomics, and targeted therapies. By fostering evidence-based discussions, the event strives to accelerate the translation of laboratory discoveries into innovative clinical solutions. A key scientific objective of the conference is to promote interdisciplinary collaboration across oncology, immunology, biotechnology, and precision medicine. Through the exchange of cutting- edge research on immune checkpoint inhibitors, CAR-T cell therapies, cancer vaccines, biomarkers, and combination treatment strategies, the meeting aims to identify new therapeutic targets and optimize patient-specific treatment approaches. The conference also emphasizes the importance of integrating artificial intelligence, big data analytics, and advanced diagnostics to enhance treatment outcomes and predictive accuracy. Furthermore, the conference is dedicated to supporting early-career researchers and encouraging global research partnerships that drive sustainable progress in cancer care. By uniting academic institutions, healthcare organizations, and industry innovators, the event seeks to establish collaborative networks that address unmet clinical needs and reduce the global burden of cancer. Ultimately, the scientific mission is to contribute to more effective, personalized, and accessible immuno-oncology treatments worldwide.